Stockscreener 앱 받기
23.64
0.13%
0.03
시간 외 거래:
23.80
0.16
+0.68%
전일 마감가:
$23.61
열려 있는:
$23.59
하루 거래량:
5.08M
Relative Volume:
0.79
시가총액:
$11.81B
수익:
$4.89B
순이익/손실:
$-242.00M
주가수익비율:
-48.34
EPS:
-0.489
순현금흐름:
$315.00M
1주 성능:
+4.00%
1개월 성능:
-8.48%
6개월 성능:
-4.60%
1년 성능:
+33.56%
1일 변동 폭
$23.44
$23.85
1주일 범위
$21.75
$23.85
52주 변동 폭
$17.11
$27.98
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.64 | 11.80B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
18.05 | 55.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.72 | 42.14B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.58 | 42.49B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
73.96 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
518.27 | 21.81B | 3.17B | 1.29B | 1.01B | 27.09 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Shiv O'neill Purchases 3,998 Shares of Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Elanco (NYSE: ELAN) legal chief buys 3,998 company shares - Stock Titan
FRAUD AND MANIPULATION—7th Cir.: Panel affirms dismissal of channel-stuffing allegations - VitalLaw.com
S&CO Inc. Buys Shares of 111,284 Elanco Animal Health Incorporated $ELAN - MarketBeat
7th Circ. Won't Revive Elanco Investors' Securities Fraud Suit - Law360
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.2% Rally? - GuruFocus
Elanco's CLiK Extra Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species - FinanzNachrichten.de
Elanco Investors Fail to Revive Sales Misrepresentation Suit (2) - Bloomberg Law News
Elanco Animal Health (ELAN) Institutional Ownership 2026 $ELAN - MarketBeat
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Director Buys 5,000 Shares - MarketBeat
Elanco Animal Health (ELAN) director purchases 5,000 shares of stock - Stock Titan
Elanco rating upgraded by Fitch on deleveraging progress - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD) - The Globe and Mail
Elanco Animal Health expands US screwworm response - foxbusiness.com
Elanco (ELAN): Innovation Is Turning A Leveraged Portfolio Into A Share-Taking Platform - Seeking Alpha
Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Elanco Animal Health (ELAN) Insider Buying: EVP and CFO Robert V - GuruFocus
Elanco receives FDA emergency authorization for screwworm spray - Investing.com
Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Speci - ACCESS Newswire
Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Buys $96,936.00 in Stock - marketbeat.com
Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock - MarketBeat
ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance - StocksToTrade
Elanco Animal Health (NYSE: ELAN) EVP granted new deferred stock units - Stock Titan
Elanco (ELAN) CFO boosts stake with 4,200-share buy and new Deferred Stock Units - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives new deferred stock unit grant - Stock Titan
Elanco Animal Health (NYSE: ELAN) director buys 10,000 shares at $23.69 - Stock Titan
Bank of America Corp DE Has $80.36 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win? - Yahoo! Finance Canada
Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus - Yahoo Finance
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigati - The National Law Review
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Elanco Animal Health Q2 Earnings Call Highlights - MarketBeat
elanco animal health inc. Positive Earnings Pre-Announcements - RTTNews
ELAN Looks 42.8% Overvalued on GF Value™ - GuruFocus
Elanco Animal Health Inc (ELAN) Shares Fall 8.6% -- GF Value Says Still Overvalued - GuruFocus
Elanco Animal Health Incorporat (ELAN) Stock forecasts - Yahoo Finance UK
ELAN Looks 35.7% Overvalued on GF Value™ as Market Prices in Fut - GuruFocus
Elanco wound spray can help protect livestock from screwworm - stocktitan.net
Elanco Animal Health (NYSE:ELAN) Sees Unusually-High Trading Volume on Analyst Upgrade - MarketBeat
Elanco Ends Lobbying Relationship With Stumptown Strategies - legis1.com
Amundi Has $2.35 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Cetera Investment Advisers Buys 65,526 Shares of Elanco Animal Health Incorporated $ELAN - marketbeat.com
UBS Adjusts Price Target on Elanco Animal Health to $33 From $31, Maintains Buy Rating - Moomoo
Elanco Animal Health Inc (ELAN) Shares Fall 7.7% -- What GF Scor - GuruFocus
Elanco CEO on Boosted Forecast, Surge in Tick Bites - Yahoo Finance
Elanco raises 2026 outlook after strong second-quarter results - Feed Strategy
UBS Group Boosts Elanco Animal Health (NYSE:ELAN) Price Target to $33.00 - marketbeat.com
Why Elanco Animal Health (ELAN) Stock Is Down Today - Quiver Quantitative
Elanco Animal Health (NYSE:ELAN) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Elanco Animal Health Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.33%
0.74%
자본화:
|
볼륨(24시간):